Diaceutics Expands US Market with New Partnerships

Diaceutics (GB:DXRX) has released an update.

Diaceutics PLC is expanding its US commercial activities by executing multiple data partnership agreements, contributing to a first-year contract value of £1.13 million. These partnerships are expected to increase revenue and Annual Recurring Revenue by leveraging partner sales teams to sell high-margin data products like DXRX Signal. The company aims to broaden its customer base, tapping into new segments and pharmaceutical brands.

For further insights into GB:DXRX stock, check out TipRanks’ Stock Analysis page.